Literature DB >> 2239671

Is obesity-related hypertension less of a cardiovascular risk? The Framingham Study.

W B Kannel1, T Zhang, R J Garrison.   

Abstract

The hypothesis that obesity-related hypertension is relatively innocuous was explored by an examination of cardiovascular events over 34 years of follow-up when related to biennially measured weights and blood pressures using time-dependent covariate proportional hazards analysis. The 5209 participants were also classified by age, cigarette smoking, and antihypertensive treatment at each of four baseline examinations with 8-year follow-up periods. Over the period of follow-up, there were 978 cardiovascular events in men and 836 in women. Risk of cardiovascular morbidity and mortality in general and of CHD in particular was as strongly related to hypertension at all levels of body mass index. This was also found to apply when adjustment was made for possible confounding by cigarette smoking. Age and smoking-adjusted absolute risks of cardiovascular events were found to be higher in hypertensive individuals with high than with low BMIs. Furthermore, the relative risk of cardiovascular disease did not vary significantly with BMI. Thus hypertension is at least as dangerous in obese as in lean persons at all ages in either sex, providing no support for the hypothesis that hypertension in the obese is more benign. This is important, since obesity predisposes to hypertension and most who have hypertension are obese. This report examines the hypothesis for CVD outcomes considered by previous reports and also the subcategories of CVD disease such as myocardial infarction and stroke, and includes data on both men and women and on young and old.

Entities:  

Mesh:

Year:  1990        PMID: 2239671     DOI: 10.1016/0002-8703(90)90136-l

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  9 in total

Review 1.  Obesity and hypertension.

Authors:  E Faloia; G Giacchetti; F Mantero
Journal:  J Endocrinol Invest       Date:  2000-01       Impact factor: 4.256

2.  Prevalence, control and awareness of high blood pressure among Canadian adults. Canadian Heart Health Surveys Research Group.

Authors:  M R Joffres; P Hamet; S W Rabkin; D Gelskey; K Hogan; G Fodor
Journal:  CMAJ       Date:  1992-06-01       Impact factor: 8.262

Review 3.  Sex Differences in Mechanisms of Hypertension Associated With Obesity.

Authors:  Jessica L Faulkner; Eric J Belin de Chantemèle
Journal:  Hypertension       Date:  2017-11-13       Impact factor: 10.190

Review 4.  Obesity and diabetic kidney disease.

Authors:  Christine Maric-Bilkan
Journal:  Med Clin North Am       Date:  2012-11-27       Impact factor: 5.456

5.  Blood pressure, body mass index and risk of cardiovascular disease in Chinese men and women.

Authors:  Hongwei Wang; Jie Cao; Jianxin Li; Jichun Chen; Xigui Wu; Xiufang Duan; Jianfeng Huang; Dongfeng Gu
Journal:  BMC Public Health       Date:  2010-04-12       Impact factor: 3.295

6.  Body mass index and cardiovascular mortality at different levels of blood pressure: a prospective study of Norwegian men and women.

Authors:  R Selmer; A Tverdal
Journal:  J Epidemiol Community Health       Date:  1995-06       Impact factor: 3.710

7.  Blood pressure variability in children with primary vs secondary hypertension.

Authors:  Daniel Leisman; Melissa Meyers; Jeremy Schnall; Nataliya Chorny; Rachel Frank; Lulette Infante; Christine B Sethna
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-04-25       Impact factor: 3.738

8.  Sex-specific responses to mineralocorticoid receptor antagonism in hypertensive African American males and females.

Authors:  John S Clemmer; Jessica L Faulkner; Alex J Mullen; Kenneth R Butler; Robert L Hester
Journal:  Biol Sex Differ       Date:  2019-05-09       Impact factor: 5.027

Review 9.  Sex hormones, aging and cardiometabolic syndrome.

Authors:  Jessica L Faulkner; Eric J Belin de Chantemèle
Journal:  Biol Sex Differ       Date:  2019-07-01       Impact factor: 5.027

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.